Combination inhibition activity of chlorhexidine and antibiotics on multidrug-resistant Acinetobacter baumannii in vitro
- PMID: 33731026
- PMCID: PMC7967118
- DOI: 10.1186/s12879-021-05963-6
Combination inhibition activity of chlorhexidine and antibiotics on multidrug-resistant Acinetobacter baumannii in vitro
Abstract
Background: Chlorhexidine is a widely used disinfectant in clinical settings and a broad-spectrum antimicrobial agent effective against aerobic and anaerobic bacteria. However, disinfectant resistant or non-susceptible bacteria, including antibiotic-resistant Acinetobacter baumannii, have been found. This study aimed to develop a new technique to prevent and control A. baumannii infection in the hospital setting.
Methods: Chlorhexidine combined with minocycline, doxycycline, meropenem, imipenem, levofloxacin and ciprofloxacin were tested against the 30 multidrug-resistant and extremely drug-resistant A. baumannii clinical isolates. The checkerboard test was used to calculate the fractional inhibitory concentration index according to the minimum inhibitory concentration value for chlorhexidine combined with antibiotics.
Results: The combination of chlorhexidine with minocycline, doxycycline, meropenem, or ciprofloxacin showed synergistic responses in all clinical isolates, and more than 50% of isolates showed FICI ≤0.5. However, chlorhexidine together with imipenem or levofloxacin showed indifferent responses in 10% and 3.33% clinical isolates, respectively. In all tests, combinations of chlorhexidine with each of the above six antibiotics showed synergistic and additive effects, and inhibited the clinical isolates.
Conclusions: We concluded that, chlorhexidine combined with antibiotics could be used to control the risk of infection with A. baumannii.
Keywords: A. baumannii; Antibiotics; Antiseptics; Chlorhexidine; In vitro.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
[In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].Mikrobiyol Bul. 2014 Apr;48(2):311-5. doi: 10.5578/mb.7104. Mikrobiyol Bul. 2014. PMID: 24819268 Turkish.
-
In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.Int J Antimicrob Agents. 2006 Mar;27(3):224-8. doi: 10.1016/j.ijantimicag.2005.10.012. Epub 2006 Feb 7. Int J Antimicrob Agents. 2006. PMID: 16464562
-
[In-vitro Activity of Ceftolozane-Tazobactam in Combination with Various Antibiotics Against Multidrug-resistant Acinetobacter baumannii Isolated from Intensive Care Patients].Mikrobiyol Bul. 2020 Jan;54(1):154-162. doi: 10.5578/mb.68981. Mikrobiyol Bul. 2020. PMID: 32050886 Turkish.
-
Antimicrobial photodynamic therapy against Acinetobacter baumannii.Photodiagnosis Photodyn Ther. 2021 Sep;35:102430. doi: 10.1016/j.pdpdt.2021.102430. Epub 2021 Jul 4. Photodiagnosis Photodyn Ther. 2021. PMID: 34233224 Review.
-
The potential for developing new antimicrobial resistance from the use of medical devices containing chlorhexidine, minocycline, rifampicin and their combinations: a systematic review.JAC Antimicrob Resist. 2020 Feb 21;2(1):dlaa002. doi: 10.1093/jacamr/dlaa002. eCollection 2020 Mar. JAC Antimicrob Resist. 2020. PMID: 34222960 Free PMC article. Review.
Cited by
-
Unveiling the synergistic potency of chlorhexidine and azithromycin in combined action.Naunyn Schmiedebergs Arch Pharmacol. 2024 Feb 20. doi: 10.1007/s00210-024-03010-0. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38376540
-
Development of an amoxicillin-radix scutellaria extract formulation and evaluation of its pharmacokinetics in pigs.BMC Vet Res. 2023 Sep 19;19(1):164. doi: 10.1186/s12917-023-03713-1. BMC Vet Res. 2023. PMID: 37726783 Free PMC article.
-
Targeting Staphylococcal Cell-Wall Biosynthesis Protein FemX Through Steered Molecular Dynamics and Drug-Repurposing Approach.ACS Omega. 2023 Aug 2;8(32):29292-29301. doi: 10.1021/acsomega.3c02691. eCollection 2023 Aug 15. ACS Omega. 2023. PMID: 37599983 Free PMC article.
-
In vitro evaluation of the antimicrobial activity of antiseptics against clinical Acinetobacter baumannii strains isolated from combat wounds.Front Microbiol. 2022 Oct 4;13:932467. doi: 10.3389/fmicb.2022.932467. eCollection 2022. Front Microbiol. 2022. PMID: 36267170 Free PMC article.
-
Meta-Analysis of the Efficacy and Safety of Chlorhexidine for Ventilator-Associated Pneumonia Prevention in Mechanically Ventilated Patients.Evid Based Complement Alternat Med. 2022 Jul 30;2022:5311034. doi: 10.1155/2022/5311034. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35942379 Free PMC article. Retracted.
References
-
- Borer A, Gilad J, Porat N, Megrelesvilli R, Saidel-Odes L, Peled N, Eskira S, Schlaeffer F, Almog Y. Impact of 4% chlorhexidine whole-body washing on multidrug-resistant Acinetobacter baumannii skin colonisation among patients in a medical intensive care unit. J Hosp Infect. 2007;67(2):149–155. doi: 10.1016/j.jhin.2007.07.023. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
